SaveHealth reports on common rheumatoid arthritis medications, highlighting their effectiveness, side effects, and cost ...

Real-world Danish registry data show that biologic drug survival in psoriasis differs between biologic-naive and ...

The transition process will begin immediately, with Ms Graver working closely with Mr Wessman and the executive team over the coming months to ensure continuity and a smooth handover. Upon assuming ...

Alvotech (NASDAQ: ALVO), a global biotechnology company specializing in the development and manufacture of biosimilar medicines for patients worldwide, today announced a USD 100 million senior term ...

Most patients receiving a GLP-1 receptor agonist (RA) and a biologic continue co-therapy for over a year with few treatment-related adverse events.

Assessing disease severity in younger patients remains complex because adult scoring tools may underestimate the disease ...

ARCALYST® (rilonacept) 2025 net product revenue of $677.5 million (unaudited), representing ~62% year-over-year growth –– ...

MoonLake requested a Type B meeting with the U.S. Food and Drug Administration (FDA) to obtain regulatory clarity and discuss the clinical evidence strategy for submission of a Biologic License ...

MoonLake regains momentum after the FDA Type B meeting allows BLA submission for sonelokimab in HS without additional trials.

There is an undeniable connection between a strong immune system and nutrition. Learn why what you eat matters and other ways to boost your immune system.

25 Most Popular TV Shows Right Now: What to Watch on Streaming Link to 25 Most Popular TV Shows Right Now: What to Watch on Streaming 30 Most Popular Movies Right Now: What to Watch In Theaters and ...

Your prescriptions could cost you a lot more soon if you don't take action now.